Dr Dubri Pharmaceuticals Private Limited
About Dr Dubri Pharmaceuticals Private Limited
Data last updated:
Dr Dubri Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2003PTC122182. Its GSTIN is 10AABCD9556C1Z2 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Himanshu Anand and Sudhanshu Anand.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at J – 1/27 First Floor (Left Side) Khirki Extn Malviya Nagar, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.11 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹3.17 Lakh (net margin 1.5%) and EBITDA of ₹8.52 Lakh (EBITDA margin 4%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 9% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹23 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dr Dubri Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressJ – 1/27 First Floor (Left Side) Khirki Extn Malviya Nagar, New Delhi, Delhi, India – 110017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dr Dubri Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr Dubri Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dr Dubri Pharmaceuticals Private Limited, buy the company report.
Financials of Dr Dubri Pharmaceuticals Private Limited
FY 2021 filings availableDr Dubri Pharmaceuticals Private Limited reported revenue of ₹2.11 Cr (down 31% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 31% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr Dubri Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dr Dubri Pharmaceuticals Private Limited
Dr Dubri Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Anand | Director | 25 Aug 2018 | 8 Years 2 Months | Current |
| Sudhanshu Anand Also directs: DRM Financial Services LLP, DRM Trading Solutions LLP, D P Gupta Associates Private Limited and 1 more | Director | 10 Sep 2003 | 23 Years 1 Months | Current |
Auditor
Dr Dubri Pharmaceuticals Private Limited is audited by ANIL K GOYAL & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL K GOYAL & ASSOCIATES | FY 2018 | 004558N |
Shareholding
The shareholding of Dr Dubri Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Dr Dubri Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2009 | 10165220 | Punjab & Sindh Bank | ₹23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dr Dubri Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr Dubri Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dr Dubri Pharmaceuticals Private Limited has a workforce of 5 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Dr Dubri Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCD9556C1Z2 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr Dubri Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dr Dubri Pharmaceuticals Private Limited has 4 board changes on record since 2003: 2 appointments and 2 cessations. The latest: Richa Gupta ceased to be Director on 19 Apr 2019.
Frequently asked questions
Dr Dubri Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 September 2003 (23+ years old) and is registered under CIN U24231DL2003PTC122182.
Dr Dubri Pharmaceuticals has 2 current directors:
- Himanshu Anand - Director
- Sudhanshu Anand - Director
The latest financial statements of Dr Dubri Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr Dubri Pharmaceuticals is 10AABCD9556C1Z2, registered in Bihar.
The CIN (Corporate Identification Number) of Dr Dubri Pharmaceuticals is U24231DL2003PTC122182. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Dubri Pharmaceuticals was incorporated on 10 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Richa Gupta ceased to be Director on 19 Apr 2019. Himanshu Anand ceased to be Additional Director on 30 Sep 2018. Himanshu Anand was appointed as Director on 25 Aug 2018. Dr Dubri Pharmaceuticals has 4 board changes on record in total.
The registered office of Dr Dubri Pharmaceuticals is at J – 127 First Floor Left Side Khirki Extn Malviya Nagar, New Delhi, Delhi, India – 110017.
Dr Dubri Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dr Dubri Pharmaceuticals has open charges of ₹23 Lakh and no satisfied charges on record as per latest MCA filings.